Ascent Solar Technologies, Inc. (NASDAQ: ASTI) completed a priced private placement on January 26, 2026 that will raise $10 million in gross proceeds from the sale of 1,818,182 shares of common stock (or pre‑funded warrants) and accompanying Series A and short‑term Series B warrants, all priced at $5.50 per share. The transaction is expected to close on or about January 26, 2026, subject to customary closing conditions. If the warrants are exercised on a cash basis, the company could receive an additional $15 million, bringing total potential proceeds to $25 million.
The financing comes at a time when Ascent Solar’s cash burn has accelerated. For the nine months ended September 30, 2025 the company reported a cash burn of $5.097 million and a working‑capital balance of $504,071. The new capital injection is intended to shore up the company’s liquidity, which has been a persistent concern given the company’s history of going‑concern warnings and a working‑capital balance that is only a few months of operating expenses.
Management explained that the proceeds will be used for general working‑capital needs, including continued investment in research and development of its flexible thin‑film photovoltaic panels for aerospace and defense applications. CEO Paul Warley said the company’s monolithic CIGS technology is uniquely suited to the rigors of space and other demanding environments, and that the capital raise will help sustain production ramp‑up and support new partnerships announced in 2025. Warley added that the company expects increased sales and revenue in 2026 as demand for lightweight, high‑efficiency solar panels grows in the space and defense markets.
Earlier in January, Ascent Solar’s shares had surged after the company announced strategic partnerships with NovaSpark and Defiant Space and outlined a 2026 production plan. The market reaction was driven by the company’s positioning in high‑growth aerospace and defense segments and the perceived value of its thin‑film technology. The private placement is part of the broader strategy to secure the capital needed to meet that demand and to address the company’s cash burn profile.
The financing will dilute existing shareholders, as the issuance of shares and warrants increases the total number of outstanding shares. However, the infusion of capital is critical for maintaining operations and pursuing the company’s growth strategy. The transaction underscores the company’s ongoing liquidity challenges but also its commitment to advancing its technology and expanding its customer base in the aerospace and defense sectors. Investors will watch how the company deploys the proceeds and whether it can convert the capital raise into sustainable revenue growth and improved cash flow.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.